The insect pathogen Bacillus thuringiensis produces an exoprotease, inhibitor A, at the beginning of the stationary growth phase. In vitro, the enzyme selectively destroys cecropins and attacins, two antibacterial proteins found in immune hemolymph from Hyalophora cecropia. The specificity of this enzyme was investigated using cecropin A(l-33) and HPLC for separation and characterization of the fragments obtained.A maximum of 12 different peptides were produced and their positions in the known sequence of cecropin A(1-33) were deduced from their amino acid compositions. The enzyme did not show a stringent requirement for a specific amino acid sequence at the cleavage site but prefers a hydrophobic residue on the C-terminal side. The specificity of the enzyme is explained in terms of the open structure of the cecropins and a pronounced inability of inhibitor A to attack globular proteins. It is generally accepted that the main insecticidal principle of the bacterium Bacillus thuringiensis resides in the proteinaceous crystal that is produced concomitantly with spore formation [8]. Compared to other bacteria B. thuringiensis is highly resistent to both cellular and humoral components of the immune system in insects. It has earlier been shown that B. thuringiensis produces two factors, inhibitor A (InA) and inhibitor B which selectively block the humoral defence system against. Escherichia coli and Bacillus cereus, respectively [9]. These extracellular factors were first found in a crystal negative mutant, Bt7. Inhibitor A was purified from the N-methyl-N'-nitro-N-nitrosoguanidine